Language: BG BG
← Back to results
Active (not recruiting) NCT03423953

Comprehensive Nano - Post Market Clinical Follow-Up Study

Conditions: Osteoarthritis Avascular Necrosis Rheumatoid Arthritis Revision Correction of Functional Deformity

Sponsor: Zimmer Biomet

trial.available_in: БГ
Overview
This data collection project is intended to provide clinical outcomes data to engineering, marketing as well as fulfill the post market surveillance requirements of various regulatory authorities. The study will be a prospective and one-arm.
Description
The Comprehensive® Shoulder System with Nano humeral component is a humeral prosthesis system intended for use in total or hemi shoulder arthroplasty surgery. Total shoulder arthroplasty consists of replacement of the humeral head and glenoid. Hemi-arthroplasty consists of replacement of only the humeral head. This project is a prospective study including one-hundred and fifty (150) anatomic and hemi cases and 44 reverse shoulders collected from up to ten (10) sites. All potential study subjects will be required to participate in the Informed Consent process.
Who can participate
Inclusion Criteria: * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. * Rheumatoid arthritis * Revision where other devices or treatments have failed * Correction of functional deformity. * Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate * Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate Exclusion Criteria: * Infection * Sepsis * osteomyelitis
Interventions
Comprehensive Nano
DEVICE
Locations 5
Austria (1)
Privatklinik Leech
Graz , Styria
Canada (1)
Kingston General Hospital
Kingston , Ontario
South Korea (2)
Chonnam National University Hospital
Gwangju , Gwangju
Samsung Medical Centre
Seoul , Seoul
United Kingdom (1)
University of Liverpool
Liverpool , Merseyside
Technical details
Status
Active (not recruiting)
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
30.10.2013
Completion date
31.07.2030
Registry ID
NCT03423953
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.